|
|
Volumn 36, Issue 5 I, 2002, Pages
|
|
National Institutes of Health Consensus Development Conference statement: Management of Hepatitis C: 2002 - June 10-12, 2002
[No Author Info available]
|
|
Author keywords
Cirrhosis; Diagnostic tests; Fibrosis; Hepatitis C; Hepatocellular carcinoma; Interferon alfa; Medical evidence; Prevention; Ribavirin
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
CONFERENCE PAPER;
CYTOPENIA;
DEPRESSION;
DIAGNOSTIC PROCEDURE;
DISEASE SEVERITY;
DRUG EFFICACY;
FLU LIKE SYNDROME;
HEMATOLOGIC DISEASE;
HEPATITIS C;
HEPATITIS C VIRUS;
HIGH RISK POPULATION;
HUMAN;
LACTIC ACIDOSIS;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER FIBROSIS;
LIVER TRANSPLANTATION;
MENTAL DISEASE;
NEUROLOGIC DISEASE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RECURRENCE RISK;
SERODIAGNOSIS;
TREATMENT INDICATION;
TREATMENT OUTCOME;
VIRUS TRANSMISSION;
EPIDEMIOLOGY;
HEPATITIS C;
HUMANS;
PATIENT SELECTION;
RESEARCH;
|
|
EID: 0036829649
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1053/jhep.2002.37117 Document Type: Conference Paper |
|
Times cited : (1022)
|
|
References (0)
|